Replies to post #97033 on Amarantus Bioscience Holdings Inc (AMBS)

[barcode27]

Here's the market cap, current PPS, and shares outstanding for each of JISGX's biotech holdings:

Mkt Cap SP Shares Out
ACAD 2620000000 26.85 97579143
XLRN 1330000000 47.46 28023599
AEGR 1510000000 51.45 29348882
AMAG 441890000 20.27 21800197
ARWR 1040000000 22.86 45494313
CMRX 683650000 25.88 26416151
EXAS 924060000 13.03 70917882
HALO 1640000000 13.47 121752042
INSM 755040000 19.23 39263651
XON 2970000000 30.64 96932115
KERX 1270000000 15.45 82200647
PTLA 1110000000 27.00 41111111
PBYI 3460000000 114.83 30131499
SNTA 360850000 4.24 85106132
THLD 297020000 5.01 59285429

I see AMBS aligning very well with the likes of SNTA and THLD after a reasonable RS. For example, if AMBS does a 15:1 RS from $.30 PPS, you wind up with $4.50 PPS and a market cap of $200M. As others have speculated earlier, it looks as if these various funds are gearing up to jump on AMBS when certain criteria are met (especially now that long-term funding is not a pressing issue).